- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Coverage Gaps Can Hamper Access To Some Breast Cancer Screening, Care
Breast cancer or the threat of it is a reality in too many women’s lives, including that of the actress Angelina Jolie as we learned earlier this month. As women mull their options for genetic testing, screening and treatment for the disease, one factor that can loom large is the extent to which their health insurance will cover whatever choices they make.
Most coverage is pretty good, experts agree, and it's getting better under the Affordable Care Act. Still, there are weak spots, and some plans are woefully inadequate. In those instances, a woman may face high out-of-pocket costs or have to appeal plan denials to get the coverage she needs.
Jolie announced that she underwent genetic testing and, after learning she has a genetic mutation that significantly increases her risk of breast and ovarian cancers, had a double mastectomy. Her mother died of ovarian cancer at age 56.
Read the full story here: http://bit.ly/18nMtba
Source: Kaiser Health News
Health Equity and Access Weekly Roundup: May 11, 2024
May 11th 2024This week's topics include frameworks for improving health equity nationwide, addressing social determinants of health, discussing CMS's Medicare rules, investigating breast cancer treatment refusal, and exploring HIV and major depressive disorder in underrepresented groups.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More
